MDS expands manufacturing facilities

Canadian radioisotope supplier MDS Nordion is expanding its radiopharmaceutical manufacturing facilities. The new wing will add approximately 80,000 square feet of space, as well as the capacity for five additional commercial-scale production suites, according to the Ottawa, Ontario-based vendor. Completion is expected in late 2003.

By staff writers
June 12, 2002

Related Reading

MDS Nordion shows oncology info management system, November 5, 2001

Radioactive microspheres treat liver cancer, October 27, 2001

Nordion begins yttrium-90 production, August 27, 2001

MDS Nordion to build new cyclotron, July 9, 2001

MDS Nordion gets OK for dose-calculation software, June 12, 2001

Copyright © 2002

Page 1 of 436
Next Page